Jan 15, 2026
Is a single dose novavax 2024/2025 jn1 enough for a SarsCov2 naive individual
A single dose of the Novavax 2024–2025 formulation (JN.1-based) is authorized for use in vaccine‑naïve individuals ≥12 years in the United States, and regulatory documents describe a single‑dose regim...